{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T07:18:28Z","timestamp":1719213508232},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,12,20]]},"DOI":"10.7759\/cureus.32756","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T23:43:35Z","timestamp":1671579815000},"source":"Crossref","is-referenced-by-count":1,"title":["Co-Occurring Subacute Combined Degeneration and Guillain-Barr\u00e9 Syndrome Resulting From Nitrous Oxide Abuse: A Case Report"],"prefix":"10.7759","author":[{"given":"Kristen","family":"Strom","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ateaya","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahideh","family":"Tabarzadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12372","article-title":"Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: a systematic review of the case literature","volume":"25","author":"Garakani A","year":"2016","unstructured":"Garakani A, Jaffe RJ, Savla D, Welch AK, Protin CA, Bryson EO, McDowell DM. Neurologic, psychiatric, and other medical manifestations of nitrous oxide abuse: a systematic review of the case literature. Am J Addict. 2016, 25:358-69. 10.1111\/ajad.12372","journal-title":"Am J Addict"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116632375","article-title":"Up: the rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use","volume":"30","author":"Kaar SJ","year":"2016","unstructured":"Kaar SJ, Ferris J, Waldron J, Devaney M, Ramsey J, Winstock AR. Up: the rise of nitrous oxide abuse. An international survey of contemporary nitrous oxide use. J Psychopharmacol. 2016, 30:395-401. 10.1177\/0269881116632375","journal-title":"J Psychopharmacol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-228001","article-title":"One month of nitrous oxide abuse causing acute vitamin B (12) deficiency with severe neuropsychiatric symptoms","volume":"12","author":"Lundin MS","year":"2019","unstructured":"Lundin MS, Cherian J, Andrew MN, Tikaria R. One month of nitrous oxide abuse causing acute vitamin B (12) deficiency with severe neuropsychiatric symptoms. BMJ Case Rep. 2019, 12:10.1136\/bcr-2018-228001","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/10550887.2020.1813361","article-title":"Nitrous oxide misuse reported to two United States data systems during 2000-2019","volume":"39","author":"Forrester MB","year":"2021","unstructured":"Forrester MB. Nitrous oxide misuse reported to two United States data systems during 2000-2019. J Addict Dis. 2021, 39:46-53. 10.1080\/10550887.2020.1813361","journal-title":"J Addict Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2014.30","article-title":"Nitrous oxide (N2O)-induced acute psychosis","volume":"41","author":"Wong SL","year":"2014","unstructured":"Wong SL, Harrison R, Mattman A, Hsiung GY. Nitrous oxide (N2O)-induced acute psychosis. Can J Neurol Sci. 2014, 41:672-4. 10.1017\/cjn.2014.30","journal-title":"Can J Neurol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/JCP.0000000000001151","article-title":"Psychiatric and other medical manifestations of nitrous oxide abuse: implications from case series","volume":"40","author":"Chien WH","year":"2020","unstructured":"Chien WH, Huang MC, Chen LY. Psychiatric and other medical manifestations of nitrous oxide abuse: implications from case series. J Clin Psychopharmacol. 2020, 40:80-3. 10.1097\/JCP.0000000000001151","journal-title":"J Clin Psychopharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000642","article-title":"Case study: naltrexone for the treatment of nitrous oxide use","volume":"14","author":"Ickowicz S","year":"2020","unstructured":"Ickowicz S, Brar R, Nolan S. Case study: naltrexone for the treatment of nitrous oxide use. J Addict Med. 2020, 14:e277-9. 10.1097\/ADM.0000000000000642","journal-title":"J Addict Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.yrtph.2015.10.017","article-title":"Recreational nitrous oxide use: prevalence and risks","volume":"73","author":"van Amsterdam J","year":"2015","unstructured":"van Amsterdam J, Nabben T, van den Brink W. Recreational nitrous oxide use: prevalence and risks. Regul Toxicol Pharmacol. 2015, 73:790-6. 10.1016\/j.yrtph.2015.10.017","journal-title":"Regul Toxicol Pharmacol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/BF03161175","article-title":"Nitrous oxide \"whippit\" abuse presenting with cobalamin responsive psychosis","volume":"2","author":"Sethi NK","year":"2006","unstructured":"Sethi NK, Mullin P, Torgovnick J, Capasso G. Nitrous oxide \"whippit\" abuse presenting with cobalamin responsive psychosis. J Med Toxicol. 2006, 2:71-4. 10.1007\/BF03161175","journal-title":"J Med Toxicol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90189-0","article-title":"Nitrous oxide, an opioid addictive agent: review of the evidence","volume":"81","author":"Gillman MA","year":"1986","unstructured":"Gillman MA. Nitrous oxide, an opioid addictive agent: review of the evidence. Am J Med. 1986, 81:97-102. 10.1016\/0002-9343(86)90189-0","journal-title":"Am J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2019.1573210","article-title":"Nitrous oxide: what do we know about its use disorder potential? Results of the French Monitoring Centre for Addiction network survey and literature review","volume":"40","author":"Fidalgo M","year":"2019","unstructured":"Fidalgo M, Prud'homme T, Allio A, Bronnec M, Bulteau S, Jolliet P, Victorri-Vigneau C. Nitrous oxide: what do we know about its use disorder potential? Results of the French Monitoring Centre for Addiction network survey and literature review. Subst Abus. 2019, 40:33-42. 10.1080\/08897077.2019.1573210","journal-title":"Subst Abus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/0960327111401437","article-title":"Death caused by addictive inhalation of nitrous oxide","volume":"30","author":"Potocka-Banas B","year":"2011","unstructured":"Potocka-Banas B, Majdanik S, Dutkiewicz G, Borowiak K, Janus T. Death caused by addictive inhalation of nitrous oxide. Hum Exp Toxicol. 2011, 30:1875-7. 10.1177\/0960327111401437","journal-title":"Hum Exp Toxicol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.2147\/SAR.S114404","article-title":"Psychiatric comorbidities in a young man with subacute myelopathy induced by abusive nitrous oxide consumption: a case report","volume":"7","author":"Mancke F","year":"2016","unstructured":"Mancke F, Kaklauskait\u0117 G, Kollmer J, Weiler M. Psychiatric comorbidities in a young man with subacute myelopathy induced by abusive nitrous oxide consumption: a case report. Subst Abuse Rehabil. 2016, 7:155-9. 10.2147\/SAR.S114404","journal-title":"Subst Abuse Rehabil"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.13048","article-title":"Nitrous oxide inhalant use disorder preceding symptoms concerning for primary psychotic illness","volume":"29","author":"Roberts D","year":"2020","unstructured":"Roberts D, Farahmand P, Wolkin A. Nitrous oxide inhalant use disorder preceding symptoms concerning for primary psychotic illness. Am J Addict. 2020, 29:525-7. 10.1111\/ajad.13048","journal-title":"Am J Addict"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/0004867417748752","article-title":"Nitrous oxide abuse presenting with acute psychosis and peripheral neuropathy","volume":"52","author":"Hew A","year":"2018","unstructured":"Hew A, Lai E, Radford E. Nitrous oxide abuse presenting with acute psychosis and peripheral neuropathy. Aust N Z J Psychiatry. 2018, 52:388. 10.1177\/0004867417748752","journal-title":"Aust N Z J Psychiatry"},{"key":"ref16","article-title":"Clinical manifestations and diagnosis of vitamin B12 and folate deficiency","author":"Means RT","year":"2022","unstructured":"Means RT, Fairfield KM. Clinical manifestations and diagnosis of vitamin B12 and folate deficiency. UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2022."},{"key":"ref17","article-title":"Guillain-Barr\u00e9 syndrome in adults: pathogenesis, clinical features and diagnosis","author":"Chandrashekhar S","year":"2022","unstructured":"Chandrashekhar S, Dimachkie MM. Guillain-Barr\u00e9 syndrome in adults: pathogenesis, clinical features and diagnosis. UpToDate. Post TW (ed): UpToDate, Waltham, MA; 2022."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/119286-co-occurring-subacute-combined-degeneration-and-guillain-barr-syndrome-resulting-from-nitrous-oxide-abuse-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:17Z","timestamp":1707507977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/119286-co-occurring-subacute-combined-degeneration-and-guillain-barr-syndrome-resulting-from-nitrous-oxide-abuse-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.32756","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,20]]}}}